Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
True North Therapeutics
Biotech
Reach for the Star: Electra nabs $84M for rare disease drugs
Electra Therapeutics is going to be reaching for some of the 7,000 rare diseases thanks to a new $84 million series B financing.
Kyle LaHucik
Feb 16, 2022 7:00am
Bioverativ, Bicycle sign $424M-plus blood disease R&D pact
Sep 6, 2017 6:50am
Bioverativ to buy True North for $400M upfront
May 23, 2017 9:06am
True North raises $45M in Series D toward rare drug trials
Oct 18, 2016 7:00am
